Earnest Partners LLC decreased its stake in Plexus Corp. (NASDAQ:PLXS – Free Report) by 4.7% in the third quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 711,566 shares of the technology company’s stock after selling 35,208 shares during the quarter. Earnest Partners LLC owned about 2.64% of Plexus worth $102,956,000 at the end of the most recent reporting period.
Several other hedge funds and other institutional investors also recently bought and sold shares of the stock. AQR Capital Management LLC grew its stake in shares of Plexus by 103.1% during the first quarter. AQR Capital Management LLC now owns 8,384 shares of the technology company’s stock valued at $1,074,000 after buying an additional 4,255 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its holdings in Plexus by 4.6% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 15,971 shares of the technology company’s stock valued at $2,046,000 after acquiring an additional 705 shares during the period. United Services Automobile Association bought a new position in Plexus in the 1st quarter valued at $218,000. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its position in Plexus by 12.9% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 79,584 shares of the technology company’s stock valued at $10,197,000 after acquiring an additional 9,078 shares during the last quarter. Finally, Bank of Montreal Can increased its stake in Plexus by 4.0% in the second quarter. Bank of Montreal Can now owns 4,488 shares of the technology company’s stock worth $607,000 after purchasing an additional 172 shares during the period. Hedge funds and other institutional investors own 94.45% of the company’s stock.
Plexus Stock Up 0.5%
NASDAQ:PLXS opened at $190.74 on Friday. The company has a debt-to-equity ratio of 0.06, a current ratio of 1.59 and a quick ratio of 0.75. Plexus Corp. has a 1-year low of $103.43 and a 1-year high of $211.84. The company has a 50-day moving average of $188.27 and a 200 day moving average of $160.05. The firm has a market cap of $5.11 billion, a PE ratio of 29.66 and a beta of 0.81.
Insider Buying and Selling at Plexus
In other news, CEO Todd P. Kelsey sold 5,231 shares of the business’s stock in a transaction on Wednesday, February 18th. The stock was sold at an average price of $195.78, for a total value of $1,024,125.18. Following the completion of the transaction, the chief executive officer directly owned 83,291 shares of the company’s stock, valued at approximately $16,306,711.98. The trade was a 5.91% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, COO Oliver K. Mihm sold 9,541 shares of Plexus stock in a transaction dated Wednesday, February 18th. The shares were sold at an average price of $201.40, for a total value of $1,921,557.40. Following the completion of the transaction, the chief operating officer owned 12,809 shares in the company, valued at $2,579,732.60. This trade represents a 42.69% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last three months, insiders have sold 47,995 shares of company stock worth $9,718,476. 1.78% of the stock is currently owned by company insiders.
Analyst Upgrades and Downgrades
A number of analysts have recently issued reports on the stock. Weiss Ratings raised shares of Plexus from a “hold (c+)” rating to a “buy (b-)” rating in a research note on Friday, March 6th. Zacks Research upgraded shares of Plexus from a “hold” rating to a “strong-buy” rating in a report on Friday, February 6th. Williams Trading set a $195.00 price objective on shares of Plexus in a research report on Wednesday, January 28th. Benchmark raised their target price on shares of Plexus from $165.00 to $195.00 and gave the stock a “buy” rating in a research report on Wednesday, January 28th. Finally, Stifel Nicolaus lifted their price target on shares of Plexus from $150.00 to $200.00 and gave the company a “hold” rating in a research note on Friday, January 30th. One analyst has rated the stock with a Strong Buy rating, three have issued a Buy rating and two have given a Hold rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $189.20.
Read Our Latest Stock Analysis on Plexus
About Plexus
Plexus Corp. (NASDAQ: PLXS) is a global provider of electronics manufacturing services (EMS) and precision engineered electronics solutions. Headquartered in Neenah, Wisconsin, the company partners with original equipment manufacturers across industries such as medical, industrial, aerospace and defense, computing, and communications. Plexus offers a full suite of services that span new product introduction, product lifecycle management, supply chain management, printed circuit board assembly, system integration, and aftermarket support.
Founded in 1979, Plexus has grown from a regional electronics assembler into a multinational organization with manufacturing and engineering centers across North America, Europe, and Asia.
Further Reading
- Five stocks we like better than Plexus
- The gold chart Wall Street is terrified of…
- Elon Musk already made me a “wealthy man”
- Silver paying 20% dividend. Plus 68% share gains
- Unlocked: Elon Musk’s Next Big IPO
- A personal warning from Martin Weiss (Please read)
Receive News & Ratings for Plexus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Plexus and related companies with MarketBeat.com's FREE daily email newsletter.
